Quantitative Cellular Intelligence for Modern Therapies
The only test that reveals whether your GLP-1, peptide therapy, or longevity protocol is actively engaging your biology at the cellular level. Baseline package ($600) covers 2 complete tests with at-home mobile phlebotomy included.
Simple,
Transparent Pricing
White-glove service — available across 42 states with mobile phlebotomy (excludes CA, CT, MA, MD, NJ, NY, PA, and RI due to state direct-access testing regulations) and expedited laboratory processing included in every package.
Reserve Priority Access for GLP-1 Response Monitoring
We are preparing our initial 42-state rollout of at-home mobile phlebotomy. Reserve your spot below to secure launch access and lock in preferred baseline pricing.
Four Nodes.
Complete Clarity.
A structured testing series that tracks your GLP-1 response from your initial baseline through long-term maintenance — giving you and your provider molecular-level visibility at every critical stage.
Baseline
Your molecular starting point
What’s Tested
Baseline mRNA transcriptomic profiling to establish your molecular starting point.
What You Learn
Your cellular baseline for future comparison, establishing the molecular foundation for tracking your GLP-1 response.
Initial Response (~1 Month)
After your baseline report
What’s Tested
Follow-up mRNA panel to assess early pathway shifts.
What You Learn
Early confirmation of downstream systemic calming across innate immune pathways.
Steady State (~3 Months)
Ongoing assessment
What’s Tested
Follow-up mRNA panel to evaluate long-term pathway adaptation.
What You Learn
Assess sustained anti-inflammatory equilibrium under maintenance dosing.
Maintenance
Annual surveillance
What’s Tested
Annual mRNA surveillance panel to detect transcriptomic drift.
What You Learn
Tracks cellular stability and active resolution tone during long-term maintenance or protocol tapering.
Standard Labs vs. Biomeme Labs
What standard labs tell you
- Blood chemistry snapshots (cholesterol, glucose, A1C)
- Lagging indicators that only change after outcomes occur
- Static numbers without trend context
- Useful but limited to surface-level health markers
What Biomeme Labs reveals
- Molecular-level response monitoring via mRNA gene expression analysis
- Leading indicators that detect changes before physical outcomes
- Cellular pathway engagement and responder classification
- Transcriptomic drift detection for long-term surveillance
- Trending across pathways and markers on your personal dashboard
Biomeme Labs does not offer standard blood work (CMP, lipid panel, CBC). The above is a comparison of testing approaches, not a product listing.
From Order to
Insight
Order Online
Choose your package — Baseline ($600) or Continuous Monitoring ($600 + $250/node) — and gain access to your personal dashboard. No doctor’s order required.
Kit Delivery
Your collection kit ships within 2 business days, typically arriving within 3–5 business days. Register your kit in your dashboard and follow the simple steps to schedule your at-home phlebotomy appointment.
At-Home Blood Draw
A certified mobile phlebotomist performs a quick blood draw at your home (under 10 minutes). The stabilized sample is shipped to our laboratory.
Molecular Analysis
Your sample is processed at our CLIA-certified high complexity laboratory. mRNA transcript profiling reveals how your body is responding.
Dashboard Results
Results are delivered via a secure notification to your personal dashboard, displaying your transcriptomic inflammation report, pathway trends, and clinical insights. Turnaround: ~1 month.
Built for
Trust
CLIA-Certified Laboratory
Every test processed under federal clinical laboratory standards at our high complexity laboratory in Philadelphia, PA.
Powered by Biomeme
Proven molecular platform trusted by clinical labs worldwide. Biomeme Labs is a subsidiary of Biomeme, Inc.
42-State Service
Available across 42 states with at-home mobile phlebotomy (excludes CA, CT, MA, MD, NJ, NY, PA, and RI due to state direct-access testing regulations). No lab visits required — we come to you.
Personal Dashboard
Secure web portal to track your transcriptomic results and molecular trends. Log in to view your metabolic report and pathway insights.
Questions Before
Ordering?
Do I need a doctor’s order?
No. Biomeme Labs offers direct consumer ordering — no prescription or doctor’s order required. We provide a complete, easy-to-understand report and encourage you to share your results with your prescribing healthcare provider to help them optimize your care.
How much does it cost?
Our GLP-1 Baseline Package is $600 (one-time) and includes 2 test nodes. For ongoing tracking, our GLP-1 Continuous Monitoring subscription starts with the same $600 baseline, then adds $250 per subsequent node at your chosen cadence (monthly, bi-monthly, or quarterly). Subscription billing is deferred until your Node 2 report is ready. Mobile phlebotomy and shipping are included in all pricing.
How does sample collection work?
For direct online consumer orders, at-home mobile phlebotomy is used exclusively. A certified mobile phlebotomist comes directly to your home or office for a quick, comfortable blood draw (in-office specimen collection is also available through our participating clinical partner practices). Available across 42 states with mobile phlebotomy (excludes CA, CT, MA, MD, NJ, NY, PA, and RI due to state direct-access testing regulations).
How long until I get results?
Results are delivered within ~1 month via a secure notification to your personal dashboard. You’ll be notified as soon as your report is ready to review.
What is the personal dashboard?
Your personal dashboard is a secure web application where you log in to view your transcriptomic results and see how your markers are trending across pathways. As our offerings expand, the dashboard will become even more comprehensive.
What GLP-1 medications are supported?
Our testing supports Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), and other GLP-1 receptor agonists. The molecular pathways we monitor are relevant across all currently available GLP-1 therapies.
Where is testing available?
Our at-home mobile phlebotomy service is available across most of the United States. Due to Direct Access Testing (DAT) regulations, we are currently unable to offer direct consumer ordering to residents in New York, New Jersey, Maryland, Rhode Island, Pennsylvania, Massachusetts, Connecticut, and California. We’re actively working to expand coverage to these states.
Ready to Start
Monitoring?
Get the only test that reveals whether your GLP-1 therapy is engaging your biology at the molecular level. Starting at $600 for your baseline package.
CLIA-certified · 42 States · Powered by Biomeme